Concepedia

Kim R. Kampen

KR

Statistics

Publications

21

Citations

888

H-Index

17

Active since

2004

Affiliations

KU Leuven(Current)

University Medical Center Groningen

VIB-KU Leuven Center for Cancer Biology

University of Groningen

Maastro Clinic

Kim R. Kampen is an author at KU Leuven specializing in oncology, molecular oncology, and medicine.

ORCID

Publications per year

2004–2023

21

Publications

21

The ribosomal protein gene RPL5 is a haploinsufficient tumor suppressor in multiple cancer types

Laura Fancello, Kim R. Kampen, Isabel Juliana Hofman et al. · Oncotarget · 2017 · 124 citations · Full text

, , +15

Translatome analysis reveals altered serine and glycine metabolism in T-cell acute lymphoblastic leukemia cells

Kim R. Kampen, Laura Fancello, Tiziana Girardi et al. · Nature Communications · 2019 · 106 citations · Full text

, , +17

Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine/Glycine Synthesis–Addicted Breast Tumor Growth

Shauni Lien Geeraerts, Kim R. Kampen, Gianmarco Rinaldi et al. · Molecular Cancer Therapeutics · 2020 · 84 citations · Full text

, , +17

The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling

Tiziana Girardi, Stijn Vereecke, Sergey O. Sulima et al. · Leukemia · 2017 · 82 citations · Full text

, , +6

The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL

Kim R. Kampen, Sergey O. Sulima, Benno Verbelen et al. · Leukemia · 2018 · 76 citations · Full text

, , +13

1–5 of 21